Teladoc Health (NYSE:TDOC) Stock Price Down 6.3%

Teladoc Health Inc (NYSE:TDOC) shares traded down 6.3% during trading on Monday . The company traded as low as $77.37 and last traded at $78.44, 1,947,352 shares changed hands during trading. An increase of 44% from the average session volume of 1,349,101 shares. The stock had previously closed at $83.74.

A number of research analysts have commented on the company. Royal Bank of Canada assumed coverage on Teladoc Health in a research note on Wednesday, November 27th. They set an “outperform” rating and a $100.00 price objective on the stock. JPMorgan Chase & Co. boosted their price objective on Teladoc Health from $82.00 to $83.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. Zacks Investment Research cut Teladoc Health from a “buy” rating to a “hold” rating and set a $89.00 price objective on the stock. in a research note on Wednesday, November 27th. Stifel Nicolaus assumed coverage on Teladoc Health in a research note on Monday, November 25th. They set a “hold” rating and a $83.00 price objective on the stock. Finally, Deutsche Bank assumed coverage on Teladoc Health in a research note on Thursday, September 12th. They set a “buy” rating and a $76.00 price objective on the stock. Four research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. Teladoc Health has a consensus rating of “Buy” and a consensus target price of $81.73.

The company has a debt-to-equity ratio of 0.44, a current ratio of 6.55 and a quick ratio of 6.55. The stock has a market capitalization of $6.06 billion, a P/E ratio of -54.47 and a beta of 1.40. The company has a fifty day moving average of $75.77 and a two-hundred day moving average of $66.84.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.28) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.40) by $0.12. The firm had revenue of $137.96 million during the quarter, compared to analyst estimates of $136.46 million. Teladoc Health had a negative return on equity of 11.23% and a negative net margin of 20.15%. Teladoc Health’s quarterly revenue was up 24.3% on a year-over-year basis. During the same period in the previous year, the company earned ($0.34) earnings per share. As a group, equities research analysts predict that Teladoc Health Inc will post -1.55 EPS for the current fiscal year.

In related news, CAO Gabriel R. Cappucci sold 9,569 shares of the business’s stock in a transaction dated Thursday, October 31st. The stock was sold at an average price of $75.00, for a total value of $717,675.00. Following the completion of the sale, the chief accounting officer now directly owns 10,798 shares of the company’s stock, valued at $809,850. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Lewis Levy sold 675 shares of the business’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $60.00, for a total value of $40,500.00. Following the completion of the sale, the insider now directly owns 4,805 shares of the company’s stock, valued at $288,300. The disclosure for this sale can be found here. Over the last three months, insiders sold 76,582 shares of company stock valued at $5,614,983. 3.14% of the stock is owned by corporate insiders.

A number of institutional investors have recently made changes to their positions in TDOC. Westside Investment Management Inc. bought a new stake in Teladoc Health in the second quarter valued at about $26,000. CNB Bank grew its holdings in shares of Teladoc Health by 100.0% during the third quarter. CNB Bank now owns 400 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 200 shares during the last quarter. Capital Investment Advisory Services LLC grew its holdings in shares of Teladoc Health by 800.0% during the third quarter. Capital Investment Advisory Services LLC now owns 450 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 400 shares during the last quarter. Cornerstone Advisors Inc. grew its holdings in shares of Teladoc Health by 187.0% during the second quarter. Cornerstone Advisors Inc. now owns 465 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 303 shares during the last quarter. Finally, Marshall Wace North America L.P. bought a new position in shares of Teladoc Health during the first quarter valued at approximately $35,000.

About Teladoc Health (NYSE:TDOC)

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Article: What is the market perform rating?

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit